ALKS - CONSENSUS CO - Alkermes plc

Historical price action for Alkermes plc (ALKS) on the GURU.Markets platform shows a trend where the metric value is 56.49. Financial stability is based on the commercialization of proprietary mental health treatments and patent protection. Alkermes plc (ALKS) maintains in-house injection production while outsourcing primary research to contractors, and delegates core manufacturing and global drug distribution to external entities.

Patent protection and high barriers to entry in the injectable drug segment ensure sustainable market dominance for Alkermes plc (ALKS). This stability is reflected in aggregated expert expectations, which assess the issuer's financial discipline through the weighted average share price. This metric measures the equilibrium point of supply and demand, signaling fundamental shifts prior to official revisions. The trend of the overall price target from investment houses allows for the timely identification of risks or growth potential.